120 related articles for article (PubMed ID: 8989261)
1. Genetic heterogeneity evidenced by low incidence of KAL-1 gene mutations in sporadic cases of gonadotropin-releasing hormone deficiency.
Georgopoulos NA; Pralong FP; Seidman CE; Seidman JG; Crowley WF; Vallejo M
J Clin Endocrinol Metab; 1997 Jan; 82(1):213-7. PubMed ID: 8989261
[TBL] [Abstract][Full Text] [Related]
2. The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics.
Oliveira LM; Seminara SB; Beranova M; Hayes FJ; Valkenburgh SB; Schipani E; Costa EM; Latronico AC; Crowley WF; Vallejo M
J Clin Endocrinol Metab; 2001 Apr; 86(4):1532-8. PubMed ID: 11297579
[TBL] [Abstract][Full Text] [Related]
3. Mutation analysis of the KAL gene in female patients with gonadotropin-releasing hormone deficiency.
Lee SH; Han JH; Cho SW; Lee WH; Cha KY; Lee MH
Yonsei Med J; 2004 Feb; 45(1):107-12. PubMed ID: 15004876
[TBL] [Abstract][Full Text] [Related]
4. A recurrent missense mutation in the KAL gene in patients with X-linked Kallmann's syndrome.
Maya-Nuñez G; Zenteno JC; Ulloa-Aguirre A; Kofman-Alfaro S; Mendez JP
J Clin Endocrinol Metab; 1998 May; 83(5):1650-3. PubMed ID: 9589672
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity in the mutations responsible for X chromosome-linked Kallmann syndrome.
Hardelin JP; Levilliers J; Blanchard S; Carel JC; Leutenegger M; Pinard-Bertelletto JP; Bouloux P; Petit C
Hum Mol Genet; 1993 Apr; 2(4):373-7. PubMed ID: 8504298
[TBL] [Abstract][Full Text] [Related]
6. The genetic and clinical heterogeneity of gonadotropin-releasing hormone deficiency in the human.
Waldstreicher J; Seminara SB; Jameson JL; Geyer A; Nachtigall LB; Boepple PA; Holmes LB; Crowley WF
J Clin Endocrinol Metab; 1996 Dec; 81(12):4388-95. PubMed ID: 8954047
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of KAL-1, GnRH-R, NELF and EBF2 genes in a series of Kallmann syndrome and normosmic hypogonadotropic hypogonadism patients.
Trarbach EB; Baptista MT; Garmes HM; Hackel C
J Endocrinol; 2005 Dec; 187(3):361-8. PubMed ID: 16423815
[TBL] [Abstract][Full Text] [Related]
8. A novel aminoterminal mutation in the KAL-1 gene in a large pedigree with X-linked Kallmann syndrome.
Gu WX; Colquhoun-Kerr JS; Kopp P; Bode HH; Jameson JL
Mol Genet Metab; 1998 Sep; 65(1):59-61. PubMed ID: 9787096
[TBL] [Abstract][Full Text] [Related]
9. Familial Kallmann syndrome: a novel splice acceptor mutation in the KAL gene.
O'Neill MJ; Tridjaja B; Smith MJ; Bell KM; Warne GL; Sinclair AH
Hum Mutat; 1998; 11(4):340-2. PubMed ID: 9554756
[TBL] [Abstract][Full Text] [Related]
10. A novel nonsense mutation of the KAL gene in two brothers with Kallmann syndrome.
Jansen C; Hendriks-Stegeman BI; Jansen M
Horm Res; 2000; 53(4):207-12. PubMed ID: 11044805
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of the gene responsible for the X chromosome-linked Kallmann syndrome.
Legouis R; Cohen-Salmon M; Del Castillo I; Petit C
Biomed Pharmacother; 1994; 48(5-6):241-6. PubMed ID: 7999985
[TBL] [Abstract][Full Text] [Related]
12. Physiologic and genetic insights into the pathophysiology and management of hypogonadotropic hypogonadism.
Hall JE
Ann Endocrinol (Paris); 1999 Jul; 60(2):93-101. PubMed ID: 10456179
[TBL] [Abstract][Full Text] [Related]
13. X-linked GnRH deficiency: role of KAL-1 mutations in GnRH deficiency.
Hu Y; Bouloux PM
Mol Cell Endocrinol; 2011 Oct; 346(1-2):13-20. PubMed ID: 21497178
[TBL] [Abstract][Full Text] [Related]
14. X chromosome-linked Kallmann syndrome: stop mutations validate the candidate gene.
Hardelin JP; Levilliers J; del Castillo I; Cohen-Salmon M; Legouis R; Blanchard S; Compain S; Bouloux P; Kirk J; Moraine C
Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8190-4. PubMed ID: 1518845
[TBL] [Abstract][Full Text] [Related]
15. Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: evidence that DAX-1 mutations lead to combined hypothalmic and pituitary defects in gonadotropin production.
Habiby RL; Boepple P; Nachtigall L; Sluss PM; Crowley WF; Jameson JL
J Clin Invest; 1996 Aug; 98(4):1055-62. PubMed ID: 8770879
[TBL] [Abstract][Full Text] [Related]
16. Renal dysgenesis and KAL1 gene defects in patients with sporadic Kallmann syndrome.
Georgopoulos NA; Koika V; Galli-Tsinopoulou A; Spiliotis BE; Adonakis G; Keramida MK; Sgourou A; Koufogiannis KD; Papachatzopoulou A; Papavassiliou AG; Kourounis G; Vagenakis GA
Fertil Steril; 2007 Nov; 88(5):1311-7. PubMed ID: 17603054
[TBL] [Abstract][Full Text] [Related]
17. Oligogenic basis of isolated gonadotropin-releasing hormone deficiency.
Sykiotis GP; Plummer L; Hughes VA; Au M; Durrani S; Nayak-Young S; Dwyer AA; Quinton R; Hall JE; Gusella JF; Seminara SB; Crowley WF; Pitteloud N
Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15140-4. PubMed ID: 20696889
[TBL] [Abstract][Full Text] [Related]
18. X chromosome-linked Kallmann syndrome: clinical heterogeneity in three siblings carrying an intragenic deletion of the KAL-1 gene.
Massin N; Pêcheux C; Eloit C; Bensimon JL; Galey J; Kuttenn F; Hardelin JP; Dodé C; Touraine P
J Clin Endocrinol Metab; 2003 May; 88(5):2003-8. PubMed ID: 12727945
[TBL] [Abstract][Full Text] [Related]
19. Kallmann syndrome: towards molecular pathogenesis.
Hardelin JP
Mol Cell Endocrinol; 2001 Jun; 179(1-2):75-81. PubMed ID: 11420131
[TBL] [Abstract][Full Text] [Related]
20. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
